USPSTF Health Maintenance Guidelines Flashcards
Breast Cancer Screening (BRCA)
- pcp screen women whove had fam members w breast, ovarian, tubal, peritoneal cancer (BRCA1, BRCA2)
- women w positive screening results should receive genetic counseling and if indicated after counseling BRCA testing
(Grade B)
recommends against routine genetic counseling or BRCA testing for women whose fam hx not assoc w increased risk for potentially harmful mutations in BRCA1 BRCA2 genes
(grade D)
Cervical cancer
–> apply to women who have a cervix, regardless of sexual hx
do NOT apply to women who received dx high grade precancerous cervical lesion or cervical cancer, women w in utero exposure to diethylstillbestrol, or immunocompromised (HIV+)
- recommend screening for cervical cancer in women 21-65 w cytology (pap smear) every 3 yrs or for women 30-65 who want to lengthen screening interval screen w combo cytology and HPV testing every 5 yrs
(grade A) - recommend against screening for cervical ca in women younger than 21 (grade D)
- against screen cervcial ca in women older than 65 whove had adequate prior screening and not otherwise at high risk for cerv ca (grade d)
- against screen for cerv ca in women who had hysterectomy w removal of cervix and who do not have hx high grade precancerous lesion (CIN grade 2 or 3) or cervical ca
- against screen for cervical ca w hPV testing, alone or in combo w cytology, in women younger than 30
Prostate cancer
No screening using PSA! (grade D)
Colorectal cancer
- recommend screening for colorectal ca using fecal occult blood testing, sigmoidoscopy, or colonoscopy in adults beginning age 50 and continuing until age 75 (grade A)
- against screen for colorectal ca in adults 76-85; but may be considerations that support colorectal ca screening in an individual pt (grade C)
- against screening for colorectal ca in adutls older than 85
- evidence insufficient to assess benefits and harms of CT colonography and fecal DNa test (grade I)
Tobacco caused diseases, tobacco use counseling
- clinicans ask all adults about tobacco use and provide tobacco cessation interventions for those who use tobacco products (grade A)
- ask all pregnant women about tobacco use and provide augmented, pregnancy-tailored counseling for those who smoke
Abdominal aortic aneurysm screening
- one time screening for AAA by ultrasonography in men 65-75 who have ever smoked (grade b)
- no rec for or against AAA screen in men 65-75 whove never smoked (grade C)
- against routine screening for AAA in women (grade d)
Aspirin
- recommend use of aspiring for men 45-79 when potential benefit of reduction in MI outweights potential harm of increase in GI hemorrhage (grade a)
- recommend use of aspirin in women 55-79 when ptoential benefit of reduction in ischemic stroke outweights potential harm of increase in GI hemorrhage (grade a)
- concludes current evidence insufficient to assess balance of benefits and harms of use of aspirin for CV dz prevention in men and women 80+ (grade I)
- recommends against use of aspirin in storke prevention in women younger than 55 and for MI prevention in men younger than age 45
Blood pressure screening (HTN)
- screening for high bp in adults 18 and older (grade A)
Lipid disorder screening in adults
Men
- strongly recommends screening men aged 35+ for lipid disorders (grade A)
- men aged 20-35 for lipid disorders if at increased risk for coronary heart dz (grade B)
Women
- strongly recommends screeing women 45+ for lipid disorders if theyre at increased risk for coronary heart dz (grade A)
- recommends screening women age 20-45 for lipid disorders if at increased risk for coronary heart disease (grade B)
makes no recommendation for or against screening for lipid disorders in men 20-35 or women 20+ who are not at increased risk for coronary heart disease
Bacteriuria
- screen for asymptomatic bacteruria w urine culture in pregnant women at 12-16 weeks’ gestation or at first prenatal visit (if later) (grade A)
- against screening for asymptomatic bacteruria in men and nonpregnant women (grade D)
Screening for chlamydia
- recommend screening for chlamydial infection in all sexually active non pregnant young women age 24 and younger and in older nonpregnant women who are at increased risk (grade A)
- screen for chlamydial infection in all pregnant women age 24 and younger an din older pregnant women at increased risk (grade B)
- against routinely providing screening for chlamydial infection in women age 25+ whether or not pregnant if not at increased risk (grade C)
- eveidence insufficient to assess balance of benefits and harms of screening for chlamydial infection in men (grade I)
Screening for gonorrhea
x
Hep b screen gen pop
recommend against routine screen in asymptomatic pop for chronic hep b virus infection (grade d)
Hep b screen pregnancy women
x
Hep c virus infection
x
hsv genital screen
x
HIV infection screen
x
Immunizations adult
x
